Inhibitory Effect of Evodiamine on Psoriasis Lesions and Itching in Mice

References

• Nestle FO, Kaplan DH, Barker J. Psoriasis. N Engl J Med. 2009;361(5):496–509. doi:10.1056/NEJMra0804595
   PubMed Web of Science ®Google Scholar
• Armstrong AW, Mehta MD, Schupp CW, et al. Psoriasis prevalence in adults in the United States. JAMA dermatol. 2021;157(8):940–946. doi:10.1001/jamadermatol.2021.2007
   PubMed Web of Science ®Google Scholar
• Hawro T, Hawro M, Zalewska-Janowska A, et al. Pruritus and sleep disturbances in patients with psoriasis. Archiv Dermatological Res. 2020;312(2):103–111. doi:10.1007/s00403-019-01998-7
   PubMed Web of Science ®Google Scholar
• Wu JJ, Feldman SR, Koo J, et al. Epidemiology of mental health comorbidity in psoriasis. J Dermatological Treat. 2018;29(5):487–495. doi:10.1080/09546634.2017.1395800
   PubMed Web of Science ®Google Scholar
• Kahremany S, Hofmann L, Harari M, et al. Pruritus in psoriasis and atopic dermatitis: current treatments and new perspectives. Pharmacol Rep. 2021;73(2):443–453. doi:10.1007/s43440-020-00206-y
   PubMed Web of Science ®Google Scholar
• Li H-J, Wu N-L, Pu C-M, et al. Chrysin alleviates imiquimod-induced psoriasis-like skin inflammation and reduces the release of CCL20 and antimicrobial peptides. Sci Rep. 2020;10(1):2932. doi:10.1038/s41598-020-60050-1
   PubMed Web of Science ®Google Scholar
• Qin J, Liao CN, Chen WW, et al. New limonoids and quinolone alkaloids with cytotoxic and anti-platelet aggregation activities from Evodia rutaecarpa (Juss.) Benth. Fitoterapia. 2021;152:104875. doi:10.1016/j.fitote.2021.104875
   PubMed Web of Science ®Google Scholar
• Sun Q, Xie L, Song J, Li X. Evodiamine: a review of its pharmacology, toxicity, pharmacokinetics and preparation researches. J Ethnopharmacol. 2020;262:113164. doi:10.1016/j.jep.2020.113164
   PubMed Web of Science ®Google Scholar
• De Prá SDT, Ferro PR, Milioli AM, et al. Antinociceptive activity and mechanism of action of hydroalcoholic extract and dichloromethane fraction of Amphilophium crucigerum seeds in mice. J Ethnopharmacol. 2017;195:283–297. doi:10.1016/j.jep.2016.11.032
   PubMed Web of Science ®Google Scholar
• Zhu X, Cheng M, Peng M, et al. Basal behavioral characterization of hsf1 deficient mice and its cellular and behavioral abnormalities underlying chronic unpredictable stressors. Behav. Brain Res. 2008;193(2):225–229. doi:10.1016/j.bbr.2008.05.024
   PubMed Web of Science ®Google Scholar
• Gangwar RS, Gudjonsson JE, Ward NL. Mouse models of psoriasis: a comprehensive review. J Invest Dermatol. 2022;142(3):884–897. doi:10.1016/j.jid.2021.06.019
   PubMed Web of Science ®Google Scholar
• Moynes DM, Vanner SJ, Lomax AE. Participation of interleukin 17A in neuroimmune interactions. Brain Behav Immun. 2014;41:1–9. doi:10.1016/j.bbi.2014.03.004
   PubMed Web of Science ®Google Scholar
• Gouin O, Lebonvallet N, L’Herondelle K, et al. Self-maintenance of neurogenic inflammation contributes to a vicious cycle in skin. Experim Dermatol. 2015;24(10):723–726. doi:10.1111/exd.12798
   PubMed Web of Science ®Google Scholar
• Nakamura M, Toyoda M, Morohashi M. Pruritogenic mediators in psoriasis vulgaris: comparative evaluation of itch-associated cutaneous factors. Br J Dermatol. 2003;149(4):718–730. doi:10.1046/j.1365-2133.2003.05586.x
   PubMed Web of Science ®Google Scholar
• Oishi N, Iwata H, Kambe N, et al. Expression of precipitating factors of pruritus found in humans in an imiquimod-induced psoriasis mouse model. Heliyon. 2019;5(6):e01981. doi:10.1016/j.heliyon.2019.e01981
   PubMed Web of Science ®Google Scholar
• Talagas M, Misery L. Role of keratinocytes in sensitive skin. Front Med. 2019;6:108. doi:10.3389/fmed.2019.00108
   PubMed Web of Science ®Google Scholar
• Stander S, Moormann C, Schumacher M, et al. Expression of vanilloid receptor subtype 1 in cutaneous sensory nerve fibers, mast cells, and epithelial cells of appendage structures. Experim Dermatol. 2004;13(3):129–139. doi:10.1111/j.0906-6705.2004.0178.x
   PubMed Web of Science ®Google Scholar
• Gouin O, L’Herondelle K, Lebonvallet N, et al. TRPV1 and TRPA1 in cutaneous neurogenic and chronic inflammation: pro-inflammatory response induced by their activation and their sensitization. Protein and Cell. 2017;8(9):644–661. doi:10.1007/s13238-017-0395-5
   PubMed Web of Science ®Google Scholar
• Wilzopolski J, Kietzmann M, Mishra SK, et al. TRPV1 and TRPA1 channels are both involved downstream of histamine-induced itch. Biomolecules. 2021;11(8):1166. doi:10.3390/biom11081166
   PubMed Web of Science ®Google Scholar
• Kim S-J, Park GH, Kim D, et al. Analysis of cellular and behavioral responses to imiquimod reveals a unique itch pathway in transient receptor potential vanilloid 1 (TRPV1)-expressing neurons. Proc Natl Acad Sci. 2011;108(8):3371–3376. doi:10.1073/pnas.1019755108
   PubMed Web of Science ®Google Scholar
• Han P, McDonald HA, Bianchi BR, et al. Capsaicin causes protein synthesis inhibition and microtubule disassembly through TRPV1 activities both on the plasma membrane and intracellular membranes. Biochem Pharmacol. 2007;73(10):1635–1645. doi:10.1016/j.bcp.2006.12.035
   PubMed Web of Science ®Google Scholar
• Um JY, Kim HB, Kim JC, et al. TRPV3 and itch: the role of TRPV3 in chronic pruritus according to clinical and experimental evidence. Int J Mol Sci. 2022;23(23):14962. doi:10.3390/ijms232314962
   PubMed Web of Science ®Google Scholar
• Cui T, Wang G, Wei N, et al. A pivotal role for the activation of TRPV3 channel in itch sensations induced by the natural skin sensitizer carvacrol. Acta Pharmacol Sin. 2018;39(3):331–335. doi:10.1038/aps.2017.152
   PubMed Web of Science ®Google Scholar
• Rosenbaum T, Benítez-Angeles M, Sánchez-Hernández R, et al. TRPV4: a physio and pathophysiologically significant ion channel. Int J Mol Sci. 2020;21(11):3837. doi:10.3390/ijms21113837
   PubMed Web of Science ®Google Scholar
• Yan J, Ye F, Ju Y, et al. Cimifugin relieves pruritus in psoriasis by inhibiting TRPV4. Cell Calcium. 2021;97:102429. doi:10.1016/j.ceca.2021.102429
   PubMed Web of Science ®Google Scholar